Topic summary

What a regulator's shortage notice actually authorises

Sourcing › Regulatory personal import research use only EMA FDA compounding Solved

This is a generated summary. It shows the 5 most-liked posts from a topic of 13, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.

bench_entryTL3Regular22 Jun 2026#1

What a regulator's shortage notice actually authorises — that is the question, and I have not found it answered plainly anywhere I have looked.

Asking what a regulator's document actually says, since the summaries of it disagree.

I have the primary document open and two secondhand accounts of it that cannot both be right. The primary document is narrower than either.

My question is whether I am reading the scope of it correctly, and what the correct reading rules out as well as what it permits.

20 likes 1mo

s.chowdhuryTL3Regular27 Jun 2026#2

An indication approved for one age range does not extend to another, and paediatric extensions are separate decisions with separate evidence.

23 likes 1mo

sourced_claimsTL3Regular10 Jul 2026#6

Post #2 put the caveat in the right place and I want to underline it.

If you can confirm or contradict a position for your own region, please date the answer. An undated regional claim is the least useful thing in this category.

31 likes 18d

y.eriksenTL2 Solution18 Jul 2026#9

Post #8 is right about the mechanism and I think understates the practical bit.

Nothing in this subcategory is legal advice, and the members who work in regulated environments are the most careful to say so.

That much is documented. The rest is how I have interpreted it.

7 likes 10d

lc_gradientTL3Analytical chemist22 Jul 2026#11

Post-authorisation safety commitments are public and are one of the more useful sources for what a regulator considered uncertain at approval.

I would not lead a decision with this, but I would not ignore it either.

30 likes 5d

Read the full topic (13 posts)

Suggested topics

Topic	Participants	Replies	Views	Activity
Enforcement priorities versus written rules Sourcing › Regulatory FDA personal import MHRA Enforcement priorities versus written rules — setting out what I have, and where I think it stops being reliable. Asking what a regulator's document actually says, since the summaries of it disagree. I have…		2	62k	15mo
Research-use-only labelling: what it means and what it does not — the long version Sourcing › Regulatory EMA research use only compounding Posting this under the heading it deserves: Research-use-only labelling: what it means and what it does not — the long version Everything below is what sits behind that. A labelling question, and I would like…	+150	158	55k	14mo
Prescription requirements and telehealth models Sourcing › Regulatory FDA compounding research use only MHRA Prescription requirements and telehealth models Writing it up because I had to work it out twice and would rather nobody else did. Proposing that prescription requirements and telehealth models deserves a…	+91	97	5.4k	7mo
Coming back to: Research-use-only labelling: what it means and what it does not Sourcing › Regulatory MHRA personal import research use only Solved Research-use-only labelling: what it means and what it does not — setting out what I have, and where I think it stops being reliable. A labelling question, and I would like the answer to be about what the…	+45	50	39k	20mo
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Sourcing › Regulatory FDA EMA compounding research use only Closed On the subject in the title: Revisiting: Why a compound being unapproved is not the same as being illegal to possess Working notes rather than a conclusion. I would like to know what people here actually do…	+76	82	52k	11mo

Related topics — sharing the tags personal import, research use only, EMA

Topic	Participants	Replies	Views	Activity
Second pass at: What to keep a record of at the point of payment Sourcing › Payments payments research use only documentation quality Second pass at: What to keep a record of at the point of payment — setting out what I have, and where I think it stops being reliable. A payments question, with the mechanics separated from the money. What I…	+14	18	1.9k	4mo
Why a compound being unapproved is not the same as being illegal to possess Sourcing › Regulatory FDA MHRA research use only EMA Why a compound being unapproved is not the same as being illegal to possess I have a specific reason for asking rather than idle curiosity, and the context is below. Collecting what is known about compound…	+72	78	23k	3mo
Research-use-only status: what it means legally and practically — does this still hold? Compounds › Other compounds custom synthesis mislabelling needs a source research use only Solved Pinned Asking directly, because I could not find a straight answer: Research-use-only status: what it means legally and practically — does this still hold? Asking about Research-use-only status directly, because I…		2	309	9mo
Naming conventions for research peptides and the confusion they cause Compounds › Other compounds custom synthesis mislabelling research use only needs a source Posting this under the heading it deserves: Naming conventions for research peptides and the confusion they cause Everything below is what sits behind that. I was wrong about naming conventions for research…	+21	25	4.9k	22d
Follow-up: UK access routes, dated and sourced Regional › UK & Ireland personal import cost per milligram MHRA Solved On the subject in the title: UK access routes, dated and sourced Working notes rather than a conclusion. Regional question, dated March 2026, because everything in this category expires. The position differs…	+10	14	27k	2d